[uam_ad id="317182"]

RIO DE JANEIRO, BRAZIL - The abrupt suspension of the coronavirus vaccine clinical trials developed by Oxford University and AstraZeneca pharmaceutical company sounded the alarm worldwide. However, Pascal Soriot, executive director of the Anglo-Swedish company, minimized the event on Thursday during a videoconference.

"It is very common, as many experts can confirm. The difference with other Subscribe to our Premium Membership Plan. Already Subscribed?